Cargando…
RUNX Family as a Promising Biomarker and a Therapeutic Target in Bone Cancers: A Review on Its Molecular Mechanism(s) behind Tumorigenesis
SIMPLE SUMMARY: The transcription factor RUNX family plays a crucial role in the formation of osteoblasts from bone marrow mesenchymal stem cells, contributing to bone development. However, emerging evidence suggests its involvement in tumor biology and cancer progression. In particular, the RUNX fa...
Autores principales: | Vimalraj, Selvaraj, Sekaran, Saravanan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296500/ https://www.ncbi.nlm.nih.gov/pubmed/37370857 http://dx.doi.org/10.3390/cancers15123247 |
Ejemplares similares
-
Flavonoids: Classification, Function, and Molecular Mechanisms Involved in Bone Remodelling
por: Ramesh, Priyanka, et al.
Publicado: (2021) -
Commentary: “Silver Nanoparticles Coated Poly(L-Lactide) Electrospun Membrane for Implant Associated Infections Prevention”
por: Vimalraj, Selvaraj, et al.
Publicado: (2021) -
Advancing postoperative pain management in humans with miRNA-based therapeutic strategies: lacunae that need to be addressed
por: Selvaraj, Vimalraj, et al.
Publicado: (2023) -
The Physiological and Pathological Role of Tissue Nonspecific Alkaline Phosphatase beyond Mineralization
por: Sekaran, Saravanan, et al.
Publicado: (2021) -
Surgical intervention as a driver of new angiogenesis in tumors—time to consider minimally invasive surgeries?
por: Selvaraj, Vimalraj, et al.
Publicado: (2023)